Creative Planning’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.24M Buy
99,354
+14,055
+16% +$979K ﹤0.01% 1020
2025
Q4
$5.66M Buy
85,299
+9,949
+13% +$643K ﹤0.01% 920
2025
Q3
$5.07M Sell
75,350
-1,880
-2% -$149K ﹤0.01% 877
2025
Q2
$6.74M Buy
77,230
+3,713
+5% +$291K 0.01% 659
2025
Q1
$5.02M Buy
73,517
+2,279
+3% +$186K ﹤0.01% 705
2024
Q4
$5.54M Buy
71,238
+11,665
+20% +$864K 0.01% 630
2024
Q3
$3.99M Buy
59,573
+10,880
+22% +$893K ﹤0.01% 729
2024
Q2
$5.52M Buy
48,693
+2,271
+5% +$287K 0.01% 575
2024
Q1
$6.44M Buy
46,422
+6,148
+15% +$773K 0.01% 533
2023
Q4
$5M Buy
40,274
+2,416
+6% +$247K 0.01% 566
2023
Q3
$3.53M Buy
37,858
+1,079
+3% +$122K ﹤0.01% 632
2023
Q2
$4.73M Buy
36,779
+2,204
+6% +$267K 0.01% 539
2023
Q1
$4.02M Buy
34,575
+2,038
+6% +$228K 0.01% 560
2022
Q4
$3.68M Buy
32,537
+3,952
+14% +$434K 0.01% 554
2022
Q3
$2.3M Buy
28,585
+2,827
+11% +$239K ﹤0.01% 656
2022
Q2
$1.92M Buy
25,758
+1,446
+6% +$132K ﹤0.01% 730
2022
Q1
$3.11M Buy
24,312
+4,296
+21% +$470K ﹤0.01% 586
2021
Q4
$2.69M Buy
20,016
+352
+2% +$50.6K ﹤0.01% 600
2021
Q3
$2.69M Sell
19,664
-3,372
-15% -$425K ﹤0.01% 591
2021
Q2
$2.46M Buy
23,036
+1,684
+8% +$162K ﹤0.01% 604
2021
Q1
$1.92M Sell
21,352
-11,816
-36% -$1.11M ﹤0.01% 752
2020
Q4
$3.07M Sell
33,168
-7,632
-19% -$681K 0.01% 510
2020
Q3
$4.21M Sell
40,800
-112
-0.3% -$11.7K 0.01% 343
2020
Q2
$4.15M Buy
40,912
+5,768
+16% +$516K 0.01% 317
2020
Q1
$2.37M Buy
35,144
+2,120
+6% +$132K 0.01% 384
2019
Q4
$1.81M Sell
33,024
-1,640
-5% -$77.8K 0.01% 550
2019
Q3
$1.29M Buy
34,664
+1,096
+3% +$42.6K ﹤0.01% 652
2019
Q2
$1.26M Sell
33,568
-8,216
-20% -$258K ﹤0.01% 672
2019
Q1
$1.24M Buy
41,784
+2,048
+5% +$72K ﹤0.01% 638
2018
Q4
$1.19M Sell
39,736
-2,128
-5% -$67.5K ﹤0.01% 608
2018
Q3
$1.5M Buy
41,864
+2,636
+7% +$81.7K 0.01% 575
2018
Q2
$931K Sell
39,228
-1,420
-3% -$30.1K ﹤0.01% 780
2018
Q1
$754K Buy
+40,648
New +$601K ﹤0.01% 877
2017
Q3
Sell
-1,888
Closed -$35K 2354
2017
Q2
$35K Buy
1,888
+368
+24% +$6.8K ﹤0.01% 2793
2017
Q1
$32K Hold
1,520
﹤0.01% 2787
2016
Q4
$23K Buy
1,520
+140
+10% +$2.48K ﹤0.01% 2980
2016
Q3
$30K Buy
1,380
+1,148
+495% +$25.6K ﹤0.01% 2729
2016
Q2
$5K Hold
232
﹤0.01% 3627
2016
Q1
$4K Sell
232
-1,588
-87% -$26.5K ﹤0.01% 3685
2015
Q4
$37K Buy
1,820
+152
+9% +$3.16K ﹤0.01% 2356
2015
Q3
$36K Buy
+1,668
New +$37.2K ﹤0.01% 2294
2015
Q2
Sell
-1,400
Closed -$22K 1588
2015
Q1
$22K Buy
+1,400
New +$21.2K ﹤0.01% 2638

Other funds holding DXCM

Creative Planning's DXCM Position: Q1 2026 in Review

Creative Planning increased its DexCom (DXCM) stake by 16% in Q1 2026, buying an estimated $979K and bringing the position to 99,354 shares worth $6.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Creative Planning first reported a position in DXCM in Q1 2015 and has held it in 42 quarters since. The position peaked at $6.74M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Creative Planning held 99,354 shares of DexCom worth $6.24M as of Q1 2026.
  • Creative Planning bought 14,055 DexCom shares in Q1 2026, an estimated $979K.
  • DexCom made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1020 holding.
  • Creative Planning first reported a position in DexCom in Q1 2015 and has held it in 42 quarters since.
  • Creative Planning's DexCom position peaked at $6.74M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.